Login / Signup

Ertapenem blood concentration: a retrospective cohort study to analyze risk of neurotoxicity.

Campany-Herrero DavidPau-Parra AlbaGonzález-Moreno PabloVima-Bofarull JaumeAnguita-Domingo DanaeMontoro-Ronsano Bruno
Published in: British journal of clinical pharmacology (2023)
In patients at risk, determining the ertapenem plasma concentration may help to minimize the risk of neurotoxicity.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes
  • patient reported